![Paul Surdez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Surdez
Contacto de Relaciones con Inversores en CATALENT, INC. .
Perfil
Paul Surdez is currently the Vice President-Investor Relations at Catalent, Inc. He previously held the same position at Laboratory Corp.
of America Holdings and Labcorp Drug Development, Inc.
Cargos activos de Paul Surdez
Empresas | Cargo | Inicio |
---|---|---|
CATALENT, INC. | Contacto de Relaciones con Inversores | 07/01/2020 |
Antiguos cargos conocidos de Paul Surdez.
Empresas | Cargo | Fin |
---|---|---|
LABCORP HOLDINGS INC. | Contacto de Relaciones con Inversores | - |
COVANCE INC. | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CATALENT, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Labcorp Drug Development, Inc.
![]() Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Laboratory Corp. of America Holdings
![]() Laboratory Corp. of America Holdings Medical/Nursing ServicesHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
- Bolsa de valores
- Insiders
- Paul Surdez